Skip to Content
Morningstar

Invesco Pharmaceuticals ETF PJP

Morningstar Medalist Rating
Medalist Rating as of | See Invesco Investment Hub

Morningstar’s Analysis PJP

Will PJP outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable PJP’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the PJP management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of PJP’s parent organization’s priorities and whether they’re in line with investors’ interests.

Invesco Pharmaceuticals ETF earns a Morningstar Medalist Rating of Negative with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PJP

More PJP Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 57.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Geron Corp

7.10 18.6 Mil
Healthcare

Eli Lilly and Co

6.02 15.8 Mil
Healthcare

Merck & Co Inc

5.97 15.6 Mil
Healthcare

Regeneron Pharmaceuticals Inc

5.77 15.1 Mil
Healthcare

AbbVie Inc

5.67 14.8 Mil
Healthcare

Amgen Inc

5.65 14.8 Mil
Healthcare

Pfizer Inc

5.59 14.6 Mil
Healthcare

Johnson & Johnson

5.56 14.5 Mil
Healthcare

Abbott Laboratories

5.50 14.4 Mil
Healthcare

ANI Pharmaceuticals Inc

4.22 11.0 Mil
Healthcare